[go: up one dir, main page]

IL165398A0 - Method for identifying immunoreactive peptides - Google Patents

Method for identifying immunoreactive peptides

Info

Publication number
IL165398A0
IL165398A0 IL16539803A IL16539803A IL165398A0 IL 165398 A0 IL165398 A0 IL 165398A0 IL 16539803 A IL16539803 A IL 16539803A IL 16539803 A IL16539803 A IL 16539803A IL 165398 A0 IL165398 A0 IL 165398A0
Authority
IL
Israel
Prior art keywords
peptides
immunoreactive peptides
identifying
tumorous
identifying immunoreactive
Prior art date
Application number
IL16539803A
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of IL165398A0 publication Critical patent/IL165398A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention relates to a method for identifying immunoreactive peptides. According to said method, a sample consisting of tumorous and corresponding healthy tissue is first prepared, the tumour-specific expression profile is subsequently determined and antigenic peptides are isolated from the tumorous tissue and analysed. The respective data that has been obtained is then matched and peptides are identified on the basis of said matched data.
IL16539803A 2002-05-29 2003-05-14 Method for identifying immunoreactive peptides IL165398A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10225139A DE10225139A1 (en) 2002-05-29 2002-05-29 Methods for the identification of immunoreactive peptides
PCT/EP2003/005038 WO2003100432A2 (en) 2002-05-29 2003-05-14 Method for identifying immunoreactive peptides

Publications (1)

Publication Number Publication Date
IL165398A0 true IL165398A0 (en) 2006-01-15

Family

ID=29557590

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16539803A IL165398A0 (en) 2002-05-29 2003-05-14 Method for identifying immunoreactive peptides
IL165398A IL165398A (en) 2002-05-29 2004-11-25 A method for identifying immunoreactive peptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL165398A IL165398A (en) 2002-05-29 2004-11-25 A method for identifying immunoreactive peptides

Country Status (13)

Country Link
EP (1) EP1508047B1 (en)
JP (1) JP2005535299A (en)
AT (1) ATE403874T1 (en)
AU (1) AU2003236645B2 (en)
CA (1) CA2486738C (en)
CY (1) CY1108358T1 (en)
DE (2) DE10225139A1 (en)
DK (1) DK1508047T3 (en)
ES (1) ES2311710T3 (en)
IL (2) IL165398A0 (en)
PT (1) PT1508047E (en)
SI (1) SI1508047T1 (en)
WO (1) WO2003100432A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2351995T3 (en) * 2004-06-17 2011-02-14 Mannkind Corporation PROFILES OF ANTIGENS ASSOCIATED WITH TUMORS IN THE DIAGNOSIS OF CANCER AND IMMUNOTHERAPY.
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
CA2651796A1 (en) * 2006-02-27 2007-09-07 Arizona Board Of Regents For And On Behalf Of Arizona State University Identification and use of novopeptides for the treatment of cancer
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
GB201004551D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
GB201019331D0 (en) * 2010-03-19 2010-12-29 Immatics Biotechnologies Gmbh Methods for the diagnosis and treatment of cancer based on AVL9
GB201004575D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
GB201006360D0 (en) 2010-04-16 2010-06-02 Immatics Biotechnologies Gmbh Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
GB201423361D0 (en) 2014-12-30 2015-02-11 Immatics Biotechnologies Gmbh Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
GB201604458D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
WO2017194170A1 (en) 2016-05-13 2017-11-16 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
KR102379955B1 (en) 2016-12-08 2022-03-29 이매틱스 바이오테크놀로지스 게엠베하 Mating Enhanced T Cell Receptor
DE102016123893A1 (en) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T cell receptors with improved binding
CN110996970A (en) 2017-06-02 2020-04-10 亚利桑那州立大学董事会 Method of creating personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
DE102018122546B3 (en) 2018-09-14 2019-12-05 Immatics Biotechnologies Gmbh High-throughput peptide MHC affinity screening method for TCR ligands
DE102019114735A1 (en) * 2019-06-02 2020-12-03 PMCR GmbH Class I and II HLA tumor antigen peptides for the treatment of breast cancer
DE102019121007A1 (en) 2019-08-02 2021-02-04 Immatics Biotechnologies Gmbh Antigen binding proteins that specifically bind to MAGE-A
US20210032370A1 (en) 2019-08-02 2021-02-04 Immatics Biotechnologies Gmbh Recruiting agent further binding an mhc molecule
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer
WO2022233956A1 (en) 2021-05-05 2022-11-10 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding prame
PE20240779A1 (en) 2021-07-27 2024-04-17 Immatics Biotechnologies Gmbh ANTIGEN-BINDING PROTEINS THAT BIND SPECIFICALLY TO CT45
WO2025021979A1 (en) 2023-07-27 2025-01-30 Immatics Biotechnologies Gmbh Novel t cell receptors targeting melanoma-associated antigen (mage) b2 and immune therapy using the same
WO2025021968A1 (en) 2023-07-27 2025-01-30 Immatics Biotechnologies Gmbh Antigen binding proteins against mageb2
LU103243B1 (en) 2024-02-09 2025-08-11 PMCR GmbH Click chemistry hla tumor antigen polypeptides and pharmaceutical composition comprising the same
WO2025168848A1 (en) 2024-02-09 2025-08-14 IMMUNEO Therapeutics GmbH Hla tumor antigen polypeptides with delivering aiding capping peptides and pharmaceutical composition comprising the same
WO2025233420A1 (en) 2024-05-07 2025-11-13 Immatics Biotechnologies Gmbh Use of anti-cancer molecules
WO2025233431A1 (en) 2024-05-07 2025-11-13 Immatics Biotechnologies Gmbh Heteromeric proteins comprising three heteromerization improving substitution, production, combinations and applications thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156317A (en) * 1996-11-12 2000-12-05 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
DE10225144A1 (en) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh Tumor-associated peptides binding to MHC molecules

Also Published As

Publication number Publication date
WO2003100432A2 (en) 2003-12-04
DE10225139A1 (en) 2004-02-26
CA2486738A1 (en) 2003-12-04
WO2003100432A3 (en) 2004-06-03
SI1508047T1 (en) 2008-12-31
ES2311710T3 (en) 2009-02-16
PT1508047E (en) 2008-10-02
EP1508047A2 (en) 2005-02-23
JP2005535299A (en) 2005-11-24
CA2486738C (en) 2011-07-12
DK1508047T3 (en) 2008-10-20
EP1508047B1 (en) 2008-08-06
CY1108358T1 (en) 2014-02-12
IL165398A (en) 2013-04-30
AU2003236645A1 (en) 2003-12-12
ATE403874T1 (en) 2008-08-15
DE50310283D1 (en) 2008-09-18
AU2003236645B2 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
IL165398A0 (en) Method for identifying immunoreactive peptides
WO2003089904A3 (en) Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
WO2004050707A3 (en) Tumor-specific recognition molecules
WO2002103532A3 (en) Data processing method
MXPA02001228A (en) System and method for determining specific requirements from general requirements documents.
DE60139542D1 (en) METHODS OF PREPARING HUMAN MONOCLONAL ANTIBODIES
CY1110295T1 (en) TRANS-9,10-DEHYDROPHOTHYLINE C AND D, ITS analogues and methods of preparation
EP1700120A4 (en) Marker for neuromyelitis optica
WO2004105574A3 (en) Image guided radiation therapy
WO2005027859A3 (en) Patch
WO2003073818A3 (en) Proteomic analysis of tumors for development of consultative report of therapeutic options
WO2004076614A3 (en) Human nucleic acid sequences obtained from prostatic carcinomas
NO972063L (en) Isolated BMP receptor kinase protein, DNA sequence, recombinant expression vector and host cell
ES2502366T3 (en) Induction of tumor immunity by folate-binding protein variants
WO2004053092A3 (en) Human pellino polypeptides
IL207012A (en) Pharmaceutical composition comprising sgp28 and a vaccine composition for the treatment of a cancer expressing sgp28
WO2003073351A3 (en) Screening process
WO2020176461A3 (en) Methods and compositions for treating neuroendocrine prostate cancer
SE9803962D0 (en) Nucleic acid encoding a nervous tissue sodium channel
WO2004020452A3 (en) Method for refolding neisserial nspa protein
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
DE50210890D1 (en) AUTOMATIC IDENTIFICATION AND / OR VERIFICATION OF RICH TEXTURES SUCH AS FINGERPRINTS
WO2003029488A3 (en) A method for the early detection of cancer
WO2003091690A3 (en) Cancer-associated nucleic acids and polypeptides